Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity
出版年份 2022 全文链接
标题
Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity
作者
关键词
-
出版物
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-30
DOI
10.1007/s00109-022-02238-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chronic restraint stress promotes the mobilization and recruitment of myeloid‐derived suppressor cells through β‐adrenergic activated CXCL5‐CXCR2‐Erk signaling cascades
- (2021) Mingyue Cao et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer
- (2021) Qian Hu et al. Frontiers in Oncology
- Propranolol suppresses the growth of colorectal cancer through simultaneously activating autologous CD8 + T cells and inhibiting tumor AKT/MAPK pathway
- (2020) Ping Liao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression
- (2019) Lois M. Ramondetta et al. GYNECOLOGIC ONCOLOGY
- The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
- (2019) Alexa Montoya et al. Biomedical Journal
- Pre-operative β-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a Phase II randomized trial
- (2019) Jonathan G Hiller et al. CLINICAL CANCER RESEARCH
- β2 adrenergic receptor–mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells
- (2019) Hemn Mohammadpour et al. JOURNAL OF CLINICAL INVESTIGATION
- Destress and do not suppress: targeting adrenergic signaling in tumor immunosuppression
- (2019) Ignacio Iñigo-Marco et al. JOURNAL OF CLINICAL INVESTIGATION
- Bloqueadores beta: perspectiva histórica y mecanismos de acción
- (2019) Eduardo Oliver et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2
- (2019) Xuan Zhang et al. Cell Death & Disease
- Infantile hemangiomas
- (2018) Rachael Hagen et al. CURRENT OPINION IN PEDIATRICS
- Propranolol for Off-label Treatment of Patients With Melanoma
- (2018) Vincenzo De Giorgi et al. JAMA Oncology
- β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress
- (2018) Guanxi Qiao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Skin cancer: Propranolol limits melanoma recurrence
- (2017) David Killock Nature Reviews Clinical Oncology
- β-Adrenergic-stimulated macrophages: Comprehensive localization in the M1-M2 spectrum
- (2016) Donald M. Lamkin et al. BRAIN BEHAVIOR AND IMMUNITY
- Sympathetic neural signaling via the β2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8+ T-cell effector function
- (2016) Leonardo D. Estrada et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The potential anticancer effect of beta-blockers and the genetic variations involved in the interindividual difference
- (2016) Ruo-Hui He et al. PHARMACOGENOMICS
- Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway
- (2016) Chengfang Zhou et al. Oncotarget
- Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response
- (2015) Winnie Yeo et al. BMC CANCER
- Molecular Mechanisms Underlying β-Adrenergic Receptor-Mediated Cross-Talk between Sympathetic Neurons and Immune Cells
- (2015) Dianne Lorton et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis
- (2015) Chih-Chien Chin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation
- (2015) Naikhoba C.O. Munabi et al. Stem Cells Translational Medicine
- Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival
- (2015) Oncotarget
- Autonomic regulation of cellular immune function
- (2014) Denise L. Bellinger et al. AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines
- (2013) Silvia Moretti et al. LABORATORY INVESTIGATION
- Effect of β-Blockers and Other Antihypertensive Drugs On the Risk of Melanoma Recurrence and Death
- (2013) Vincenzo De Giorgi et al. MAYO CLINIC PROCEEDINGS
- Propranolol inhibits endothelial progenitor cell homing: a possible treatment mechanism of infantile hemangioma
- (2012) Hai-Xiao Zou et al. CARDIOVASCULAR PATHOLOGY
- β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway
- (2011) Dong Zhang et al. Molecular Cancer
- Stimulation of β2-adrenergic receptors inhibits calcineurin activity in CD4+ T cells via PKA–AKAP interaction
- (2010) Carsten Riether et al. BRAIN BEHAVIOR AND IMMUNITY
- Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression
- (2008) Eric V. Yang et al. BRAIN BEHAVIOR AND IMMUNITY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started